Establishment of the Ivermectin Research for Malaria Elimination Network: updating the research agenda

[1]  C. Chaccour,et al.  Screening for an ivermectin slow-release formulation suitable for malaria vector control , 2015, Malaria Journal.

[2]  Teun Bousema,et al.  Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  R. Steketee,et al.  Ivermectin as a complementary strategy to kill mosquitoes and stop malaria transmission? , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  Teun Bousema,et al.  The potential impact of adding ivermectin to a mass treatment intervention to reduce malaria transmission: a modelling study. , 2014, The Journal of infectious diseases.

[5]  Kevin C. Kobylinski,et al.  Evaluation of ivermectin mass drug administration for malaria transmission control across different West African environments , 2014, Malaria Journal.

[6]  Kevin C. Kobylinski,et al.  Rationale for the coadministration of albendazole and ivermectin to humans for malaria parasite transmission control. , 2014, The American journal of tropical medicine and hygiene.

[7]  D. Kaslow,et al.  Development of a transmission-blocking malaria vaccine: progress, challenges, and the path forward. , 2014, Vaccine.

[8]  T. Aye,et al.  Challenges in universal coverage and utilization of insecticide-treated bed nets in migrant plantation workers in Myanmar , 2014, Malaria Journal.

[9]  F. Nosten,et al.  Population Pharmacokinetic Assessment of the Effect of Food on Piperaquine Bioavailability in Patients with Uncomplicated Malaria , 2014, Antimicrobial Agents and Chemotherapy.

[10]  M. Panchal,et al.  Plasmodium falciparum signal recognition particle components and anti-parasitic effect of ivermectin in blocking nucleo-cytoplasmic shuttling of SRP , 2014, Cell Death and Disease.

[11]  R. Hunt,et al.  An online tool for mapping insecticide resistance in major Anopheles vectors of human malaria parasites and review of resistance status for the Afrotropical region , 2014, Parasites & Vectors.

[12]  J. Burrows,et al.  Designing the next generation of medicines for malaria control and eradication , 2013, Malaria Journal.

[13]  Q. Bassat,et al.  Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination , 2013, Malaria Journal.

[14]  A. Maqbool,et al.  Efficacy of Ivermectin for Control of Zoophilic Malaria Vectors in Pakistan , 2013 .

[15]  C. Bourguinat,et al.  P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: Prospects for reversing transport-dependent anthelmintic resistance. , 2012, International journal for parasitology. Drugs and drug resistance.

[16]  Kevin C Kobylinski,et al.  Ivermectin inhibits the sporogony of Plasmodium falciparum in Anopheles gambiae , 2012, Malaria Journal.

[17]  N. Govella,et al.  Why Use of Interventions Targeting Outdoor Biting Mosquitoes will be Necessary to Achieve Malaria Elimination , 2012, Front. Physio..

[18]  Kevin C. Kobylinski,et al.  Ivermectin mass drug administration to humans disrupts malaria parasite transmission in Senegalese villages. , 2011, The American journal of tropical medicine and hygiene.

[19]  J. Okeibunor,et al.  Where would I be without ivermectin? Capturing the benefits of community‐directed treatment with ivermectin in Africa , 2011, Tropical medicine & international health : TM & IH.

[20]  Kevin C. Kobylinski,et al.  Mass drug administration of ivermectin in south-eastern Senegal reduces the survivorship of wild-caught, blood fed malaria vectors , 2010, Malaria Journal.

[21]  Massamba Sylla,et al.  The effect of oral anthelmintics on the survivorship and re-feeding frequency of anthropophilic mosquito disease vectors. , 2010, Acta tropica.

[22]  J. Lines,et al.  Effect of ivermectin on Anopheles gambiae mosquitoes fed on humans: the potential of oral insecticides in malaria control. , 2010, The Journal of infectious diseases.

[23]  F. Nosten,et al.  Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria , 2010, European Journal of Clinical Pharmacology.

[24]  J. McCarthy,et al.  Permethrin and ivermectin for scabies. , 2010, The New England journal of medicine.

[25]  B. Giraudeau,et al.  Oral ivermectin versus malathion lotion for difficult-to-treat head lice. , 2010, The New England journal of medicine.

[26]  G. Stygall.  “Did They Really Say That?” , 2008 .

[27]  M. Enserink,et al.  Did They Really Say ... Eradication? , 2007, Science.

[28]  M. Enserink,et al.  Malaria. Did they really say ... eradication? , 2007, Science.

[29]  K. Lasseter,et al.  Safety, Tolerability, and Pharmacokinetics of Escalating High Doses of Ivermectin in Healthy Adult Subjects , 2002, Journal of clinical pharmacology.

[30]  B. Arison,et al.  Identification of cytochrome P4503A4 as the major enzyme responsible for the metabolism of ivermectin by human liver microsomes. , 1998, Xenobiotica; the fate of foreign compounds in biological systems.

[31]  M. Boussinesq,et al.  Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection , 1997, The Lancet.

[32]  T. Geary,et al.  Ivermectin distribution in the plasma and tissues of patients infected with Onchocerca volvulus , 1996, European Journal of Clinical Pharmacology.

[33]  B. Greene,et al.  Community-based treatment of onchocerciasis with ivermectin: safety, efficacy, and acceptability of yearly treatment. , 1991, The Journal of infectious diseases.